Barbara Klink

27PUBLICATIONS

170CO-AUTHORS

Epigenetics (incl. genome methylation and epigenomics)Cancer geneticsRegenerative medicine (incl. stem cells)Predictive and prognostic markersMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|Jun 09, 2026

Hereditary cancer: Germline testing practices across ERN GENTURIS member countries.

|Mar 11, 2026

Validation structures for sequence variants of uncertain significance in hereditary cancer.

Morghan C Lucas, Thomas Keßler, Anna Benet-Pagès

|Feb 13, 2026

Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study.

J Matt McCrary, Els Van Valckenborgh, Denis Horgan

|May 03, 2025

A series of reviews in familial cancer: genetic cancer risk in context variants of uncertain significance in MMR genes: which procedures should be followed?

Morghan C Lucas, Thomas Keßler, Florentine Scharf

|Feb 03, 2025

Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile.

Audrey Burban, Cloe Tessier, Mathieu Larroquette

|Mar 16, 2024

Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro

Pageof 5

Frequent Collaborators

Doreen William

Susan Richter

Barbara Hutter

Benedikt Brors

Sebastian Bauer

Stefan Fröhling

Peter Horak

Evelin Schröck

Melanie Boerries

Christoph E Heilig

Frequent Collaborators

Doreen William

Susan Richter

Barbara Hutter

Benedikt Brors